Literature DB >> 20171618

Steroid profiles in ovarian follicular fluid in women with and without polycystic ovary syndrome, analyzed by liquid chromatography-tandem mass spectrometry.

Tord Naessen1, Mark M Kushnir, Andrey Chaika, Jelena Nosenko, Iryna Mogilevkina, Alan L Rockwood, Kjell Carlstrom, Jonas Bergquist, Dmitrijus Kirilovas.   

Abstract

OBJECTIVE: To compare steroid concentrations and steroid product-to-precursor ratios in ovarian follicular fluid (FF) from women with polycystic ovary syndrome (PCOS) and from regularly menstruating women in their early follicular phase, using liquid chromatography-tandem mass spectrometry (LC-MS/MS). Polycystic ovary syndrome involves abnormal regulation of the steroidogenic enzymes, leading to arrest of follicle development.
DESIGN: Case-control study.
SETTING: University hospital clinic. PATIENT(S): Follicular fluid from size-matched ovarian follicles (5-8 mm) in 27 nonstimulated women with PCOS and in 21 women without PCOS was sampled. Thirteen steroids were quantitated from 40 μL of FF, using LC-MS/MS. INTERVENTION(S): None. MAIN OUTCOME MEASURE(S): Concentrations of steroids in the FF and product-to-precursor ratios (enzyme activity) were compared between the groups. RESULT(S): In women with PCOS, ovarian FF contained higher concentrations of individual and total androgens, lower individual and total estrogens (E), and a lower total E-to-androgen ratio, compared with regularly menstruating women. The product-to-precursor concentration ratios indicated higher CYP17-linked and lower CYP19-linked (aromatase) enzyme activity. Receiver operating characteristic plots indicated the early CYP17 step (17-OH5P/5P) being highly important for the prevalence of PCOS (c=0.95). CONCLUSION(S): The women with PCOS had higher ovarian CYP17-linked and lower CYP19-linked (aromatase) enzyme activity, confirming previous data. Multiple steroid assessments from minute volumes including FF from nonstimulated ovaries, using LC-MS/MS, might be useful in research, clinical endocrinology, and in IVF.
Copyright © 2010 American Society for Reproductive Medicine. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20171618     DOI: 10.1016/j.fertnstert.2009.12.081

Source DB:  PubMed          Journal:  Fertil Steril        ISSN: 0015-0282            Impact factor:   7.329


  20 in total

1.  Long non-coding RNA TUG1 and its molecular mechanisms in polycystic ovary syndrome.

Authors:  Ying Li; Jun Zhang; Yu-Dong Liu; Xing-Yu Zhou; Xin Chen; Jing Zhe; Qing-Yan Zhang; Xiao-Fei Zhang; Ying-Xue Chen; Zhe Wang; Shi-Ling Chen
Journal:  RNA Biol       Date:  2020-07-02       Impact factor: 4.652

2.  Chronically elevated androgen and/or consumption of a Western-style diet impairs oocyte quality and granulosa cell function in the nonhuman primate periovulatory follicle.

Authors:  Cecily V Bishop; Taylor E Reiter; David W Erikson; Carol B Hanna; Brittany L Daughtry; Shawn L Chavez; Jon D Hennebold; Richard L Stouffer
Journal:  J Assist Reprod Genet       Date:  2019-06-11       Impact factor: 3.412

3.  Single-cell expression analysis of BMP15 and GDF9 in mature oocytes and BMPR2 in cumulus cells of women with polycystic ovary syndrome undergoing controlled ovarian hyperstimulation.

Authors:  Luciana Ochuiuto Teixeira de Resende; Alessandra Aparecida Vireque; Laura Ferreira Santana; Daniel Antunes Moreno; Ana Carolina Japur de Sá Rosa e Silva; Rui Alberto Ferriani; Carlos Alberto Scrideli; Rosana Maria Reis
Journal:  J Assist Reprod Genet       Date:  2012-07-24       Impact factor: 3.412

4.  Hyperactive LH Pulses and Elevated Kisspeptin and NKB Gene Expression in the Arcuate Nucleus of a PCOS Mouse Model.

Authors:  Lourdes A Esparza; Danielle Schafer; Brian S Ho; Varykina G Thackray; Alexander S Kauffman
Journal:  Endocrinology       Date:  2020-04-01       Impact factor: 4.736

Review 5.  Animal Models to Understand the Etiology and Pathophysiology of Polycystic Ovary Syndrome.

Authors:  Elisabet Stener-Victorin; Vasantha Padmanabhan; Kirsty A Walters; Rebecca E Campbell; Anna Benrick; Paolo Giacobini; Daniel A Dumesic; David H Abbott
Journal:  Endocr Rev       Date:  2020-07-01       Impact factor: 19.871

6.  Genetic association study from North India to analyze association of CYP19A1 and CYP17A1 with polycystic ovary syndrome.

Authors:  Ratneev Kaur; Tajinder Kaur; Anupam Kaur
Journal:  J Assist Reprod Genet       Date:  2018-03-22       Impact factor: 3.412

7.  A Novel Letrozole Model Recapitulates Both the Reproductive and Metabolic Phenotypes of Polycystic Ovary Syndrome in Female Mice.

Authors:  Alexander S Kauffman; Varykina G Thackray; Genevieve E Ryan; Kristen P Tolson; Christine A Glidewell-Kenney; Sheila J Semaan; Matthew C Poling; Nahoko Iwata; Kellie M Breen; Antoni J Duleba; Elisabet Stener-Victorin; Shunichi Shimasaki; Nicholas J Webster; Pamela L Mellon
Journal:  Biol Reprod       Date:  2015-07-22       Impact factor: 4.285

Review 8.  Follicular Fluid: A Powerful Tool for the Understanding and Diagnosis of Polycystic Ovary Syndrome.

Authors:  Ana Teresa Brinca; Ana Cristina Ramalhinho; Ângela Sousa; António Hélio Oliani; Luiza Breitenfeld; Luís A Passarinha; Eugenia Gallardo
Journal:  Biomedicines       Date:  2022-05-27

9.  Revisiting hyper- and hypo-androgenism by tandem mass spectrometry.

Authors:  Flaminia Fanelli; Alessandra Gambineri; Marco Mezzullo; Valentina Vicennati; Carla Pelusi; Renato Pasquali; Uberto Pagotto
Journal:  Rev Endocr Metab Disord       Date:  2013-06       Impact factor: 6.514

10.  Effect of glucocorticoid-induced insulin resistance on follicle development and ovulation.

Authors:  Katherine S Hackbart; Pauline M Cunha; Rudelle K Meyer; Milo C Wiltbank
Journal:  Biol Reprod       Date:  2013-06-20       Impact factor: 4.285

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.